Top of the morning to you. Gray skies are hovering over the Pharmalot corporate campus, but our spirits remain sunny. And why not? This inspires us to trot out one of our favorite sayings, courtesy of the morning mayor: 'Every brand new day should be unwrapped like a precious gift.' So while you tug on the ribbon, here are a few items to get you started. Have a great day, everyone, and smile...
Merck To Buy Back Up To $5 Billion In Stock (Reuters)
Teva Resumes Manufacturing At California Site (Orange County Business Journal)
J&J Agrees To Buy Synthes For $21.3 Billion (Bloomberg News)
Supreme Court Skeptical About Vermont Data Mining Law (Bellingham Herald)
Lupin May Wait To Sell Birth Control Pills In The US (Bloomberg News)
Merck And Biogen Expand Facilities In North Carolina (InPharma Technologist)
Drugmakers Try New Ways To Improve Trial Enrollment (Outsourcing Pharma)
Lilly And Medtronic To Develop Parkinson's Treatment (Indianapolis Business Journal)
Abbott Sued Over Claim Humira Caused Nerve Damage (Bloomberg News)
Epileptic Kids Do Not Take Meds As Prescribed (HealthDay)
Pfizer Sutent Patient Will Talk About His 'Miracle' (Vancouver Sun)
Regeneron & Sanofi Colorectal Cancer Drug Extends Lives (Bloomberg News)
1 Comment
Stop reimbursing clinical investigators so generously for screen failures and dropouts and you will see higher rates of study completion.